FFIV vs KYTX · P/E 32, rev $3.09B vs $488.8M cap
F5 Networks Inc (FFIV) versus Kyverna Therapeutics, Inc. Common Stock (KYTX) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
KYTX does not have a complete income-statement cache yet.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. KYTX currently screens at market cap $488.8M.
Not investment advice. Open the FFIV and KYTX stock pages for the full models.
Not investment advice.